Trial Profile
A Phase 1 Placebo-Controlled Study To Assess The Safety, Tolerability And Pharmacokinetics Of PF-05161704 After Administration Of Single Escalating Oral Doses Under Fed And Fasted Conditions In Healthy Volunteers.
Status:
Completed
Phase of Trial:
Phase I
Latest Information Update: 24 Jul 2019
Price :
$35
*
At a glance
- Drugs PF 5161704 (Primary)
- Indications Type 2 diabetes mellitus
- Focus Adverse reactions; Pharmacokinetics
- 23 Sep 2010 Status changed from recruiting to completed as reported by ClinicalTrials.gov.
- 03 Sep 2010 New trial record